Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Jon G. Tepsick
Observed names:
J. Tepsick,
Jon Tepsick,
Tepsick, Jon
Institution:
Duke University
Observed institutions:
Duke University,
Xavier University
ORCID:
0000-0001-6035-7800
Observed ORCID:
0000-0001-6035-7800
OpenAlex ID:
A5001086098
Clinical and economic impact of recurrence in early-stage non-small-cell lung cancer following complete resection
2023
·
Howard West
, Xiaohan Hu
, et al.
·
Future Oncology
·
15
Real-world treatment patterns, recurrence, and overall survival of patients with muscle-invasive bladder cancer undergoing radical cystectomy in U.S. oncology practice
2026
·
Patrick Squires
, Francesca Coutinho
, et al.
·
Urologic Oncology Seminars and Original Investigations
·
9
Improving Real-World Mortality Data Quality in Oncology Research: Augmenting Electronic Medical Records With Obituary, Social Security Death Index, and Commercial Claims Data
2023
·
Ping Shao
, Jon G. Tepsick
, et al.
·
JCO Clinical Cancer Informatics
·
9
PDF
A retrospective analysis of treatment patterns, overall survival, and real-world disease-free survival in early-stage non-small cell lung cancer following complete resection
2024
·
Xiaohan Hu
, Diana Chirovsky
, et al.
·
BMC Pulmonary Medicine
·
8
Real-World Use Patterns and Clinical Outcomes for Myelodysplastic Syndrome Patients Initiating Oral Decitabine and Cedazuridine or Intravenous/Subcutaneous Hypomethylating Agents
2024
·
Amer M. Zeidan
, Ruizhi Zhao
, et al.
·
Blood
·
5
PDF
Goserelin 3-month depot shows non-inferiority to the monthly formulation in U.S. patients with premenopausal breast cancer: a real-world evidence study
2025
·
Kelly E. McCann
, Noran Osman
, et al.
·
Breast Cancer Research and Treatment
·
4
Cost-minimization analysis of negative pressure wound therapy technologies for the treatment of moderate-to-severe foot infections
2020
·
Peter J Mallow
, Jon Tepsick
, et al.
·
Journal of Comparative Effectiveness Research
·
4
HSD64 Real-World Adjuvant Nivolumab Utilization in Surgically Treated Muscle-Invasive Bladder Cancer Patients within U.S. Community Oncology Practice
2025
·
Patrick J. Squires
, Francesca Coutinho
, et al.
·
Value in Health
·
2
Real-world Treatment and Clinical Outcomes in Patients With Metastatic Castration-resistant Prostate Cancer Treated With Olaparib in the United States
2025
·
Daniel J. George
, Furaha Kariburyo-Yay
, et al.
·
Urologic Oncology Seminars and Original Investigations
·
2
Recurrence and its association with overall survival (OS) in muscle-invasive bladder cancer (MIBC) patients undergoing radical cystectomy (RC): A real-world analysis.
2025
·
Patrick Squires
, Jon G. Tepsick
, et al.
·
Journal of Clinical Oncology
·
2
Real-world clinical outcomes of patients (Pts) with metastatic colorectal cancer (mCRC) who received trifluridine-tipiracil (FTD-TPI) monotherapy or FTD-TPI + bevacizumab (FTD-TPI+bev) combination therapy.
2025
·
Maliha Nusrat
, Ruizhi Zhao
, et al.
·
Journal of Clinical Oncology
·
2
PDF
Real-world clinical outcomes, genetic testing patterns, and treatment patterns of patients with metastatic castration-resistant prostate cancer treated with olaparib monotherapy in the United States
2026
·
Daniel J. George
, Furaha Kariburyo-Yay
, et al.
·
Urologic Oncology Seminars and Original Investigations
·
1
Real-world study of use patterns and clinical outcomes for patients with myelodysplastic syndrome initiating oral decitabine and cedazuridine or intravenous/subcutaneous hypomethylating agents
2026
·
Amer M. Zeidan
, Ruizhi Zhao
, et al.
·
Therapeutic Advances in Hematology
·
1
Real-world clinical outcomes of trifluridine-tipiracil monotherapy (FTD-TPI) and FTD-TPI + bevacizumab combination therapy (FTD-TPI+bev) in 639 black patients (pts) with metastatic colorectal cancer (mCRC).
2025
·
Maliha Nusrat
, Ruizhi Zhao
, et al.
·
Journal of Clinical Oncology
·
1
PDF
Real-world baseline treatment patterns and overall survival (rwOS) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) treated with olaparib in the United States.
2024
·
Furaha Kariburyo-Yay
, Daniel J. George
, et al.
·
Journal of Clinical Oncology
·
1
PDF
Real-world homologous recombination repair mutation (HRRm) testing patterns in patients with metastatic castration-resistant prostate cancer (mCRPC) treated with olaparib in the United States.
2024
·
Daniel J. George
, Furaha Kariburyo-Yay
, et al.
·
Journal of Clinical Oncology
·
1
Real-world treatment patterns and clinical outcomes among cholangiocarcinoma patients treated with futibatinib or pemigatinib.
2026
·
Amit Mahipal
, Dina Christensen
, et al.
·
Journal of Clinical Oncology
PDF
Abstract P1-08-09: Real-World Outcomes Comparing 3-Monthly with Monthly Goserelin Implant in Premenopausal Women with Breast Cancer
2025
·
Kelly E. McCann
, Noran Osman
, et al.
·
Clinical Cancer Research
Real-world patient characteristics and treatment patterns among cholangiocarcinoma patients treated with FGFR inhibitors.
2025
·
Amit Mahipal
, Ruizhi Zhao
, et al.
·
Journal of Clinical Oncology
PDF
PIH25 Comparative Effectiveness Analysis of a Pediatric Co-Management Program
2021
·
J. Tepsick
, A. Eberhart
, et al.
·
Value in Health
Pdb35 a Cost Minimization Analysis of Negative Pressure Wound Therapy Technologies for the Treatment of Moderate to Severe Foot Infections
2020
·
P. Mallow
, J. Tepsick
, et al.
·
Value in Health
Show more works
View as search
Works count:
23
Citation count:
67
H-index:
5
I10-index:
1
Year
Topic
Type